Biphasic nature of inotropic action of nitric oxide donor NOC7 in guinea-pig ventricular trabeculae

Japanese Journal of Physiology

Volumn 49, Issue 4, 1999, Pages 389-394

  Ohba, Mitsuyoshi ^a   Kawata, Hiroshi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

escin; Cardiac muscle; Contractility; Nitric oxide

Indexed keywords

CAFFEINE; CALCIUM; ESCIN; GUANYLATE CYCLASE; NITRIC OXIDE DONOR; PROPIONAMIDE DERIVATIVE;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; FEMALE; GUINEA PIG; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; INOTROPISM; MALE; MUSCLE TONE; MUSCLE TWITCH; MYOFILAMENT; NONHUMAN; SARCOPLASMIC RETICULUM; SKINNED MUSCLE FIBER;

ANIMALS; FEMALE; GUINEA PIGS; HISTOLOGICAL TECHNIQUES; HYDRAZINES; MALE; MYOCARDIAL CONTRACTION; NITRIC OXIDE DONORS; VENTRICULAR FUNCTION;

EID: 0032711502     PISSN: 0021521X     EISSN: None     Source Type: Journal    
DOI: 10.2170/jjphysiol.49.389     Document Type: Article

References (25)

1. Kelly RA, Balligand J-L, and Smith TW: Nitric oxide and cardiac function. Circ Res 79: 363-380, 1996
2. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, and Harding SE: Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265: H176-H182, 1993
3. Sterin-Borda L, Echagüe AV, Leiros CP, Genaro A, and Borda E: Endogenous nitric oxide signalling system and the cardiac muscarinic acetylcholine receptor-inotropic response. Br J Pharmacol 115: 1525-1531, 1995
4. Flesch M, Kilter H, Cremers B, Lanz O, Südkamp M, Kuhn-Regnier F, and Böhm M: Acute effects of nitric oxide and cyclic GMP on human myocardial contractility. J Pharmcol Exp Ther 281: 1340-1349, 1997
5. Ito N, Bartunek J, Spitzer KW, and Lorell BH: Effects of the nitric oxide donor sodium nitroprusside on intracellular pH and contraction in hypertrophied myocytes. Circulation 95: 2303-2311, 1997
6. Kojda G, Kottenberg K, Nix P, Schlüter KD, Piper HM, and Noack E: Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes. Circ Res 78: 91-101, 1996
7. Mohan P, Brutsaert DL, Paulus WJ, and Sys SU: Myocardial contractile response to nitric oxide and cGMP. Circulation 93:1223-1229, 1996
8. Kojda G, Brixius K, Kottenberg K, Nix P, Schlüter K-D, Piper HM, and Noack E: The new NO donor SPM3672 increases cGMP and improves contraction in rat cardiomyocytes and isolated heart. Eur J Pharmacol 284: 315-319, 1995
9. Weyrich AS, Ma X-L, Buerke M, Murohara T, Armstead VE, Lefer AM, Nicolas JM, Thomas AP, Lefer DJ, and Vinten-Johansen J: Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res 75: 692-700, 1994
10. Nawrath H, Bäumner D, Rupp J, and Oelert H: The ineffectiveness of the NO-cyclic GMP signaling pathway in the atrial myocardium. Br J Pharmacol 116: 3061-3067, 1995
11. Wyeth RP, Temma K, Seifen E, and Kennedy RH: Negative inotropic actions of nitric oxide require high doses in rat cardiac muscle. Pflügers Arch 432: 678-684, 1996
12. Kirstein M, Rivet-Bastide M, Hatem S, Bénardeau A, Mercadier J-J, and Fischmeister R: Nitric oxide regulates the calcium current in isolated human atrial myocytes. J Clin Invest 95: 794-802, 1995
13. Campbell DL, Stamler JS, and Strauss HC: Redox modulation of L-type calcium channels in ferret ventricular myocytes: dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 108: 277-293, 1996
14. + channel openers in guinea-pig ventricular cells. Br J Pharmacol 120: 1568-1574, 1997
15. Stoyanovsky D, Murphy T, Anno PR, Kim Y-M, and Salama G: Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21: 19-29, 1997
16. 2+ in intact cardiac myocytes. Circ Res 74: 970-978, 1994
17. Ohba M and Kawata H: Contractility of α-toxin permeabilized ventricular muscle of guinea pig. Jpn J Physiol 44: 509-518, 1994
18. Ishida Y, Hashimoto M, Fukushima S, Matsumura S, Sasaki T, Nakayama K, Tamura K, Murakami E, Isokawa S, and Momose K: A nitric oxide-sensitive electrode: requirement of lower oxygen concentration for detecting nitric oxide from the tissue. J Pharmacol Toxicol Methods 35: 19-24, 1996
19. Fujishiro N and Kawata H: A program for calculating the total concentrations of ligands and metals at any temperature, ionic strength and pH for solutions with a controlled metal concentration. Comput Biol Med 25: 61-80, 1995
20. Nims RW, Cook JC, Krishna MC, Christodoulou D, Poore CMB, Miles AM, Grisham MB, and Wink DA: Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol 268: 93-105, 1996
21. Keefer LK, Nims RW, Davies KM, and Wink DA: "NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol 268: 281-293, 1996
22. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, and Mayer B: Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Mol Pharmacol 48:184-188, 1995
23. 2+ current elicited by withdrawal of acetylcholine in cat atrial myocytes. J Gen Physiol 111: 113-125, 1998
24. Ohba M: Effects of nitric oxide donor (NOC7) on the contractility of guinea-pig ventricular muscle fiber. Jpn J Physiol 48: S58, 1998
25. Ito M and Karachot L: Protein kinases and phosphatase inhibitors mediating long-term desensitization of gulutamate receptors in cerebellar Purkinje cells. Neurosci Res 14: 27-38, 1992